BHQ

CAS No. 88-58-4

BHQ( —— )

Catalog No. M20884 CAS No. 88-58-4

BHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BHQ
  • Note
    Research use only, not for human use.
  • Brief Description
    BHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
  • Description
    BHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
  • In Vitro
    DTBHQ influences arachidonic acid (AA) metabolism in biologically relevant concentrations in vitro.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    Ca2+-ATPase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    88-58-4
  • Formula Weight
    222.32
  • Molecular Formula
    C14H22O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10mg/mL(44.98mM)
  • SMILES
    CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O
  • Chemical Name
    25-Di-tert-butylhydroquinone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fusi F Saponara S Gagov H et al. 25-Di-t-butyl-14-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+channel?via?superoxide anion generation?[J]. British Journal of Pharmacology 2001 133(7):988-996.
molnova catalog
related products
  • Oligomycin A

    Oligomycin A, created by Streptomyces, acts as a mitochondrial F0F1-ATPase inhibitor, with a Ki of 1 μM.

  • Mtb ATP synthase-IN-...

    Mtb ATP synthase-IN-1 (compound 6ab) is a potent inhibitor of Mycobacterium tuberculosis (Mtb) ATP synthase (MIC = 0.452-0.499 μg/mL) that can be used in anti-mycobacterium research, showing low cytotoxicity (Vero IC 50 > 64 μg/mL) and acceptable oral bioavailability with good metabolic stability.

  • Thevetin B

    Thevetin B is a cardiac glycoside. Thevetin A and thevetin B are Na+-, K+-dependent adenosinetriphosphatase (Na+,K+-ATPase) (EC 3.6.1.3) inhibitors.